Evidence map›Paper›PMID 39272129›Full record

SynthesisJournal of neuroengineering and rehabilitation2024

Simulating space walking: a systematic review on anti-gravity technology in neurorehabilitation.

Mirjam Bonanno, Maria Grazia Maggio, Angelo Quartarone, Alessandro Marco De Nunzio, Rocco Salvatore Calabrò

Erratum issuedAbstract readSystematic Review
In one paragraph

Synthesis in Journal of neuroengineering and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mirjam BonannoIRCCS Centro Neurolesi Bonino-Pulejo, Via Palermo, SS 113, C. da Casazza, Messina, 98124, Italy.
Maria Grazia MaggioIRCCS Centro Neurolesi Bonino-Pulejo, Via Palermo, SS 113, C. da Casazza, Messina, 98124, Italy.
Angelo QuartaroneIRCCS Centro Neurolesi Bonino-Pulejo, Via Palermo, SS 113, C. da Casazza, Messina, 98124, Italy.
Alessandro Marco De NunzioLUNEX, Differdange, Luxembourg.
Rocco Salvatore CalabròIRCCS Centro Neurolesi Bonino-Pulejo, Via Palermo, SS 113, C. da Casazza, Messina, 98124, Italy. roccos.calabro@irccsme.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurological disorders, such as Parkinson's disease (PD), multiple sclerosis (MS), cerebral palsy (CP) and stroke are well-known causes of gait and balance alterations. Innovative devices (i.e., robotics) are often used to promote motor recovery. As an alternative, anti-gravity treadmills, which were developed by NASA, allow early mobilization, walking with less effort to reduce gait energy costs and fatigue. A systematic search, according to PRISMA guidelines, was conducted for all peer-reviewed articles published from January 2010 through September 2023, using the following databases: PubMed, Scopus, PEDro and IEEE Xplore. After an accurate screening, we selected only 16 articles (e.g., 5 RCTs, 2 clinical trials, 7 pilot studies, 1 prospective study and 1 exploratory study). The evidence collected in this systematic review reported promising results in the field of anti-gravity technology for neurological patients, in terms of improvement in gait and balance outcomes. However, we are not able to provide any clinical recommendation about the dose and parameters of anti-gravity treadmill training, because of the lack of robust high-quality RCT studies and large samples. Registration number CRD42023459665.

Indexed as

Neurological RehabilitationWalkingExercise TherapyHumansAnti-gravity technologyAnti-gravity treadmillNeurological disordersNeurorehabilitation

Identifiers

PMID39272129
PMCPMC11395184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.